Trial Profile

Amyloid Imaging and Cognitive Impairment After Intracerebral Hemorrhage

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 14 Jan 2020

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Florbetapir F 18 (Primary)
Indications Cerebral amyloid angiopathy; Intracranial haemorrhages
Focus Diagnostic use
Acronyms COGHIC-AV45

Most Recent Events

20 Sep 2018 Status changed from recruiting to completed.
19 Jul 2017 Results assessing florbetapir retention in cerebral amyloid angiopathy-related hemorrhages (n=33) published in the Neurology
21 Feb 2017 Planned End Date changed from 1 Dec 2015 to 1 Jun 2017.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com